Frank Mccormick - Net Worth and Insider Trading

Over the past 18 months, Frank Mccormick made 1 insider transaction in BridgeBio Pharma Inc (BBIO) with a net sale of 100,000. Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 1,034,094 shares made by Neil Kumar , a net sale of 412,388 shares made by Brian C Stephenson , and a net sale of 9,500 shares made by Randal W Scott .

In summary, during the past 3 months, insiders sold 2,500 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 3,064,727 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,064,727 shares.

BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Frank Mccormick made no insider transaction in Exelixis Inc (EXEL). Other recent insider transactions involving Exelixis Inc (EXEL) include a net sale of 247,500 shares made by Jeffrey Hessekiel , a net sale of 166,722 shares made by Patrick J. Haley , and a net purchase of 190,000 shares made by David Edward Johnson .

In summary, during the past 3 months, insiders sold 66,225 shares of Exelixis Inc (EXEL) in total and bought 190,000 shares, with a net purchase of 123,775 shares. During the past 18 months, 916,236 shares of Exelixis Inc (EXEL) were sold and 310,409 shares were bought by its insiders, resulting in a net sale of 605,827 shares.

Exelixis Inc (EXEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Frank Mccormick made no insider transaction in Chinook Therapeutics Inc (KDNY). Other recent insider transactions involving Chinook Therapeutics Inc (KDNY) include a net sale of 21,804 shares made by Andrew James King , a net sale of 95,785 shares made by Eric Dobmeier , and a net sale of 28,266 shares made by Tom Frohlich .

In summary, during the past 3 months, insiders sold 0 shares of Chinook Therapeutics Inc (KDNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453,260 shares of Chinook Therapeutics Inc (KDNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453,260 shares.

Chinook Therapeutics Inc (KDNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Frank Mccormick made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 263,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 8,742 shares made by Kovacs Shane William Charles .

In summary, during the past 3 months, insiders sold 75,000 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 75,000 shares. During the past 18 months, 398,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,255,932 shares were bought by its insiders, resulting in a net purchase of 1,857,858 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.